Conference abstract · 31 Oct 2016
Conference abstractPublished 6 Oct 2015
A DNA aptamer targeting the PA endonuclease domain provided cross-protection against infections of different subtypes of influenza A virus
University of Hong Kong, Hong Kong
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Amino acid residues in the N-terminal of the PA subunit (PAN) of the Influenza A polymerase play critical roles in endonuclease activity, protein stability and vRNA promoter binding. In addition, PAN is highly conserved among different subtypes of the influenza virus, which suggests PAN to be a desirable target for the development of anti-influenza agents. We selected DNA aptamers targeting the intact PA protein or the PAN domain of an H5N1 virus strain using systematic evolution of ligands by exponential enrichment (SELEX). Binding affinities of selected aptamers were measured, followed by evaluation of in vitro endonuclease inhibitory activity. Next, antiviral effects of enriched aptamers against influenza A virus infections were further examined. A total of three aptamers targeting PA and six aptamers targeting PAN were selected. Our data demonstrated that all three PA-selected aptamers neither inhibited endonuclease activity nor exhibited antiviral efficacy, whereas four of the six PAN-selected aptamers inhibited both endonuclease activity and H5N1 virus infection. These results suggested that PAN functional domain might be a better target than the intact PA protein for the screening of antiviral agents. Among the four effective aptamers, one exhibited cross-protection against infections of H1N1, H5N1, H7N7 and H7N9 influenza viruses with 50% inhibitory concentration (IC50) around 10 nM. Notably, this aptamer was identified at the 5th round but disappeared after the 10th round of the selection, suggesting that the identification and evaluation of aptamers at early rounds of the selection may be highly helpful for screening effective aptamers. Overall, our study provides novel insights for screening and developing effective aptamers as anti-influenza drugs.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 29 Oct 2024
Cross-Protection: How Pre-existing H1N1 Immunity Mitigates Severe H5N1 Influenza Disease
Conference abstract
An H5N1 based matrix protein 2 ectodomain tetrameric peptide vaccine provided cross-protection against lethal infection of H7N9 influenza virus
Conference abstract · 2018
Cross-protection to new drifted influenza A (H3) viruses and prevalence of protective antibodies to seasonal influenza, between 2014 in Portugal
Conference abstract · 31 Oct 2016
Structural basis of the influenza virus resistance against a viral endonuclease inhibitor L-742,001
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 14 Apr 2026
Ethiopian Child Immunization Coverage Prevalence and Determinants: Evidence from the 2019 Mini-Demographic and Health Survey
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Bojian Zheng”
- BylineArticles whose byline prints “Shuofeng Yuan”
- BylineArticles whose byline prints “Jie Zhou”
